Scarica l'app Stockscreener
283.85
1.07%
-3.07
Dopo l'orario di chiusura:
283.58
-0.27
-0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$286.92
Aprire:
$284.085
Volume 24 ore:
2.58M
Relative Volume:
1.13
Capitalizzazione di mercato:
$152.81B
Reddito:
$34.76B
Utile/perdita netta:
$6.62B
Rapporto P/E:
23.21
EPS:
12.23
Flusso di cassa netto:
$10.61B
1 W Prestazione:
-1.43%
1M Prestazione:
-4.39%
6M Prestazione:
-8.67%
1 anno Prestazione:
-14.12%
Intervallo 1D:
$280.38
$286.93
Intervallo di 1 settimana:
$280.38
$288.74
Portata 52W:
$253.30
$339.17
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
283.85 | 154.47B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
737.83 | 659.07B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.00 | 428.83B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
211.86 | 374.37B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
128.23 | 245.16B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.18 | 213.51B | 63.43B | 16.42B | 14.72B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen Inc. $AMGN Shares Sold by Smead Capital Management Inc. - MarketBeat
The Manufacturers Life Insurance Company Purchases 600,096 Shares of Amgen Inc. $AMGN - MarketBeat
Zacks Research Predicts Amgen's Q3 Earnings (NASDAQ:AMGN) - MarketBeat
Decoding the Genetics of Obesity - Amgen
Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 - Endpoints News
Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential - MSN
Amgen Stock (AMGN) Slips on $600M Research Hub News - TipRanks
Amgen (AMGN) Unveils US$600 Million Innovation Hub Expanding R&D Efforts in California - simplywall.st
Amgen’s Strategic Focus and Portfolio Strength Justify Buy Rating Despite Bemarituzumab Challenges - TipRanks
Amgen dips after trial update for Zai Lab partnered gastric cancer therapy - Seeking Alpha
Amgen Inc. stock trend forecast2025 Macro Impact & Daily Volume Surge Signals - Newser
First Manhattan CO. LLC. Has $30.64 Million Position in Amgen Inc. $AMGN - MarketBeat
GW Henssler & Associates Ltd. Lowers Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by First Financial Bankshares Inc - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Ameriflex Group Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Ieq Capital LLC - MarketBeat
Amgen Inc. $AMGN Stock Holdings Increased by Landscape Capital Management L.L.C. - MarketBeat
Trexquant Investment LP Sells 36,293 Shares of Amgen Inc. $AMGN - MarketBeat
Canada Pension Plan Investment Board Sells 145,702 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Raised by Calton & Associates Inc. - MarketBeat
Using data models to predict Amgen Inc. stock movementJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Will Amgen Inc. benefit from macro trends2025 Big Picture & Free High Return Stock Watch Alerts - Newser
Should you hold or exit Amgen Inc. nowJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
Amgen invests big in new science and innovation center - The Pharma Letter
Applying chart zones and confluence areas to Amgen Inc.July 2025 Final Week & Capital Protection Trading Alerts - Newser
Evergreen Capital Management LLC Purchases 1,213 Shares of Amgen Inc. $AMGN - MarketBeat
CreativeOne Wealth LLC Increases Position in Amgen Inc. $AMGN - MarketBeat
Jump Financial LLC Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Tema Etfs LLC Trims Position in Amgen Inc. $AMGN - MarketBeat
Amgen to invest $600m in new US science and innovation hub - Pharmaceutical Technology
Will Amgen Inc. see short term momentumSell Signal & High Return Stock Watch Alerts - Newser
FORA Capital LLC Has $227,000 Stock Position in Amgen Inc. $AMGN - MarketBeat
Navigating Sector Divergence: Nio, Signet, and Amgen in a Shifting Market - AInvest
Amgen Inc. $AMGN Shares Purchased by OMERS ADMINISTRATION Corp - MarketBeat
Why Amgen Inc. is moving todayProfit Target & AI Forecasted Stock Moves - Newser
News | Amgen extends pharmaceutical real estate push with planned California hub - CoStar
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.76%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):